Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06512883 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06512883 · ClinicalTrials.gov record · last posted 2026-08-24

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Study acronym: CLIPS
StatusRecruiting
PhasePhase 3
Started2025-04-17
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The main purpose of study is to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of benralizumab.

Protocol amendment history 1 change detected by DataLookout

2026-05-30
Completion pushed: 2028-04-03 → 2029-05-14
Trial Details
NCT Number NCT06512883
Lead Sponsor AstraZeneca
Conditions Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
Enrollment 14 participants
Start Date 2025-04-17
Primary Completion 2028-02-20 (estimated)
Study Completion 2029-05-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-24